Malihe Rezaee

Dr. Malihe Rezaee


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 May 2023 in Frontiers in Cardiovascular Medicine
Verified
Journal Article
Open access
NHNeda Hedayati
Neda Hedayati
AYAlireza Yaghoobi
Alireza Yaghoobi
MSMarziyeh Salami
Marziyeh Salami
YGYasaman Gholinezhad
Yasaman Gholinezhad
FAFarnaz Aghadavood
Farnaz Aghadavood
MRMalihe Rezaee
Malihe Rezaee
Polyphenols are abundant in regular diets and possess antioxidant, anti-inflammatory, anti-cancer, neuroprotective, and cardioprotective effects. Regarding the inadequacy of the current treatments in preventing cardiac remodeling following cardiovascular diseases, attention has been focused on improving cardiac function with potential alternatives such as polyphenols. The following online databases were searched for relevant orginial published from 2000 to 2023: EMBASE, MEDLINE, and Web of Science databases. The search strategy aimed to assess the effects of polyphenols on heart failure and keywords were “heart failure” and “polyphenols” and “cardiac hypertrophy” and “molecular mechanisms”. Our results indicated polyphenols are repeatedly indicated to regulate various heart failure-related vital molecules and signaling pathways, such as inactivating fibrotic and hypertrophic factors, preventing mitochondrial dysfunction and free radical production, the underlying causes of apoptosis, and also improving lipid profile and cellular metabolism. In the current study, we aimed to review the most recent literature and investigations on the underlying mechanism of actions of different polyphenols subclasses in cardiac hypertrophy and heart failure to provide deep insight into novel mechanistic treatments and direct future studies in this context. Moreover, due to polyphenols' low bioavailability from conventional oral and intravenous administration routes, in this study, we have also investigated the currently accessible nano-drug delivery methods to optimize the treatment outcomes by providing sufficient drug delivery, targeted therapy, and less off-target effects, as desired by precision medicine standards.

6 July 2023 in Cellular and Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
AMAlireza Mafi
Alireza Mafi
RMReza Mannani
Reza Mannani
SKShayan Khalilollah
Shayan Khalilollah
NHNeda Hedayati
Neda Hedayati
RSRaziyeh Salami
Raziyeh Salami
RAReza Akhavan-Sigari
Reza Akhavan-Sigari

14 August 2023 in Frontiers in Pharmacology
Verified
Journal Article
Open access
AMAlireza Mafi
Alireza Mafi
HRHamidreza Rismanchi
Hamidreza Rismanchi
YGYasaman Gholinezhad
Yasaman Gholinezhad
MMMohaddese Malek Mohammadi
Mohaddese Malek Mohammadi
VMVahide Mousavi
Vahide Mousavi
HMHamed Mirzaei
Hamed Mirzaei
Leukaemia is a dangerous malignancy that causes thousands of deaths every year throughout the world. The rate of morbidity and mortality is significant despite many advancements in therapy strategies for affected individuals. Most antitumour medications used now in clinical oncology use apoptotic signalling pathways to induce cancer cell death. Accumulated data have shown a direct correlation between inducing apoptosis in cancer cells with higher tumour regression and survival. Until now, the efficacy of melatonin as a powerful antitumour agent has been firmly established. A change in melatonin concentrations has been reported in multiple tumours such as endometrial, hematopoietic, and breast cancers. Findings show that melatonin’s anticancer properties, such as its prooxidation function and ability to promote apoptosis, indicate the possibility of utilizing this natural substance as a promising agent in innovative cancer therapy approaches. Melatonin stimulates cell apoptosis via the regulation of many apoptosis facilitators, including mitochondria, cytochrome c, Bcl-2, production of reactive oxygen species, and apoptosis receptors. This paper aimed to further assess the anticancer effects of melatonin through the apoptotic pathway, considering the role that cellular apoptosis plays in the pathogenesis of cancer. The effect of melatonin may mean that it is appropriate for use as an adjuvant, along with other therapeutic approaches such as radiotherapy and chemotherapy.

27 April 2023 in European Journal of Pharmacology
Verified
Journal Article
Closed access
AMAlireza Mafi
Alireza Mafi
AKAtoosa Keshavarzmotamed
Atoosa Keshavarzmotamed
NHNeda Hedayati
Neda Hedayati
ZBZahra Yeganeh Boroujeni
Zahra Yeganeh Boroujeni
Russel ReiterRussel Reiter
Russel Reiter
ZAZatollah Asemi
Zatollah Asemi

12 July 2023 in EXCLI Journal
Verified
Journal Article
Open access
MAMina Alimohammadi
Mina Alimohammadi
YGYasaman Gholinezhad
Yasaman Gholinezhad
VMVahide Mousavi
Vahide Mousavi
SKSamaneh Kahkesh
Samaneh Kahkesh
MRMalihe Rezaee
Malihe Rezaee
MAMahmood Araghi
Mahmood Araghi
Circular RNAs (CircRNAs) are a class of regulatory RNA transcripts, which are ubiquitously expressed in eukaryotes. CircRNA dysregulation has been shown to disrupt the interaction of the Wnt/β-catenin pathway, which regulates several biological processes involved in tumorigenesis, thereby contributing to the development and progression of cancer. Interactions of tumor-derived circRNAs with the Wnt/β-catenin signaling pathway provide both clinical diagnostic biomarkers and promising therapeutic targets. In this review, we outlined current evidence on the roles of circRNAs associated with the Wnt/β-catenin pathway in regulating lung cancer formation and development. We believe that our findings will assist in the advancement or establishment of circRNA-based lung cancer therapeutic approaches.

13 May 2024 in Heliyon
Verified
Journal Article
Open access
PJPooya Jalali
Pooya Jalali
AYAlireza Yaghoobi
Alireza Yaghoobi
MRMalihe Rezaee
Malihe Rezaee
MZMohammad Reza Zabihi
Mohammad Reza Zabihi
MPMoein Piroozkhah
Moein Piroozkhah
ZSZahra Salehi
Zahra Salehi
Esophageal adenocarcinoma (EAC) is a common cancer with a poor prognosis in advanced stages. Therefore, early EAC diagnosis and treatment have gained attention in recent decades. It has been found that various pathological changes, particularly Barrett's Esophagus (BE), can occur in the esophageal tissue before the development of EAC. In this study, we aimed to identify the molecular contributor in BE to EAC progression by detecting the essential regulatory genes that are differentially expressed in both BE and EAC. We conducted a comprehensive bioinformatics analysis to detect BE and EAC-associated genes. The common differentially expressed genes (DEGs) and common single nucleotide polymorphisms (SNPs) were detected using the GEO and DisGeNET databases, respectively. Then, hub genes and the top modules within the protein-protein interaction network were identified. Moreover, the co-expression network of the top module by the HIPPIE database was constructed. Additionally, the gene regulatory network was constructed based on miRNAs and circRNAs. Lastly, we inspected the DGIdb database for possible interacted drugs. Our microarray dataset analysis identified 92 common DEGs between BE and EAC with significant enrichment in skin and epidermis development genes. The study also identified 22 common SNPs between BE and EAC. The top module of PPI network analysis included SCEL, KRT6A, SPRR1A, SPRR1B, SPRR3, PPL, SPRR2B, EVPL, and CSTA. We constructed a ceRNA network involving three specific mRNAs, 23 miRNAs, and 101 selected circRNAs. According to the results from the DGIdb database, TD101 was found to interact with the KRT6A gene. The present study provides novel potential candidate genes that may be involved in the molecular association between Esophageal adenocarcinoma and Barrett's Esophagus, resulting in developing the diagnostic tools and therapeutic targets to prevent progression of BE to EAC.